These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36516105)

  • 1. Re-Examining Cannabidiol: Conversion to Tetrahydrocannabinol Using Only Heat.
    Daniels R; Yassin OA; Toribio JM; Gascón JA; Sotzing G
    Cannabis Cannabinoid Res; 2024 Apr; 9(2):486-494. PubMed ID: 36516105
    [No Abstract]   [Full Text] [Related]  

  • 2. Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada.
    Hammond D; Goodman S
    Cannabis Cannabinoid Res; 2022 Jun; 7(3):345-354. PubMed ID: 33998866
    [No Abstract]   [Full Text] [Related]  

  • 3. An assessment of qualitative and quantitative cannabinoids analysis in selected commercially available cannabis oils in Argentina.
    Fernández N; Cappello MG; Quiroga PN
    Forensic Sci Int; 2023 Aug; 349():111762. PubMed ID: 37392612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial.
    Zamarripa CA; Spindle TR; Surujunarain R; Weerts EM; Bansal S; Unadkat JD; Paine MF; Vandrey R
    JAMA Netw Open; 2023 Feb; 6(2):e2254752. PubMed ID: 36780161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of CBD, Δ
    Jaidee W; Siridechakorn I; Nessopa S; Wisuitiprot V; Chaiwangrach N; Ingkaninan K; Waranuch N
    Cannabis Cannabinoid Res; 2022 Aug; 7(4):537-547. PubMed ID: 34096805
    [No Abstract]   [Full Text] [Related]  

  • 6. Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration.
    Sholler DJ; Spindle TR; Cone EJ; Goffi E; Kuntz D; Mitchell JM; Winecker RE; Bigelow GE; Flegel RR; Vandrey R
    J Anal Toxicol; 2022 May; 46(5):494-503. PubMed ID: 34089060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids.
    Hindelang P; Scharinger A; Richling E; Walch SG; Lachenmeier DW
    Front Biosci (Landmark Ed); 2022 Jul; 27(8):228. PubMed ID: 36042166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of Relevant Thermal Conversion of Cannabidiol to Tetrahydrocannabinol in E-Cigarette Vapor and Low-Tetrahydrocannabinol Cannabis Smoke.
    Hindelang P; Scharinger A; Golombek P; Laible M; Tamosaite S; Walch SG; Lachenmeier DW
    Cannabis Cannabinoid Res; 2022 Oct; 7(5):616-620. PubMed ID: 36169637
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemical transformation of cannabidiol into psychotropic cannabinoids under acidic reaction conditions: Identification of transformed products by GC-MS.
    Jeong M; Lee S; Seo C; Kwon E; Rho S; Cho M; Kim MY; Lee W; Lee YS; Hong J
    J Food Drug Anal; 2023 Mar; 31(1):165-176. PubMed ID: 37224558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores.
    Spindle TR; Sholler DJ; Cone EJ; Murphy TP; ElSohly M; Winecker RE; Flegel RR; Bonn-Miller MO; Vandrey R
    JAMA Netw Open; 2022 Jul; 5(7):e2223019. PubMed ID: 35857320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of Δ
    Greenwood LM; Broyd SJ; van Hell HH; Todd J; Jones A; Murray RM; Croft RJ; Michie PT; Solowij N
    Psychopharmacology (Berl); 2022 May; 239(5):1409-1424. PubMed ID: 34719731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potency trends of cannabis in Jamaica during the period of 2014 to 2020.
    Lindsay CM; Bernard KK; Hammond AM; Beckford S; Abel WD; Brown PD; Young LE
    Drug Test Anal; 2024 Feb; 16(2):174-186. PubMed ID: 37309060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Dark Side of Cannabidiol: The Unanticipated Social and Clinical Implications of Synthetic Δ
    Geci M; Scialdone M; Tishler J
    Cannabis Cannabinoid Res; 2023 Apr; 8(2):270-282. PubMed ID: 36264171
    [No Abstract]   [Full Text] [Related]  

  • 14. A new Cannabis genome assembly associates elevated cannabidiol (CBD) with hemp introgressed into marijuana.
    Grassa CJ; Weiblen GD; Wenger JP; Dabney C; Poplawski SG; Timothy Motley S; Michael TP; Schwartz CJ
    New Phytol; 2021 May; 230(4):1665-1679. PubMed ID: 33521943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public interest in ∆
    Leas EC; Nobles AL; Shi Y; Hendrickson E
    Int J Drug Policy; 2022 Mar; 101():103557. PubMed ID: 34952279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the cannabis as medicine survey 2020 (CAMS-20) Australia-wide study.
    Trevitt BT; Bailey S; Mills L; Arkell TR; Suraev A; McGregor IS; Lintzeris N
    PLoS One; 2024; 19(2):e0297092. PubMed ID: 38354169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CannaCount: an improved metric for quantifying estimates of maximum possible cannabinoid exposure.
    Lambros AM; Sagar KA; Dahlgren MK; Kosereisoglu D; El-Abboud C; Smith RT; Gruber SA
    Sci Rep; 2023 Apr; 13(1):5869. PubMed ID: 37041309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating sex differences in acute intoxication and verbal memory errors after ad libitum cannabis concentrate use.
    Gibson LP; Gust CJ; Ellingson JM; YorkWilliams SL; Sempio C; Klawitter J; Bryan AD; Hutchison KE; Cinnamon Bidwell L
    Drug Alcohol Depend; 2021 Jun; 223():108718. PubMed ID: 33866072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model.
    Casey SL; Mitchell VA; Sokolaj EE; Winters BL; Vaughan CW
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.